Stimulus-specific activation and actin dependency of distinct, spatially separated ERK1/2 fractions in A7r5 smooth muscle cells

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Vetterkind, Susanne ^a   Saphirstein, Robert J ^a   Morgan, Kathleen G ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

12 DEOXYPHORBOL DERIVATIVE; ACTIN; CALDESMON; CAVEOLIN 1; CYTOCHALASIN; MITOGEN ACTIVATED PROTEIN KINASE 3; PHORBOL ESTER; SMALL INTERFERING RNA; CALMODULIN BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; PHORBOL 13 ACETATE 12 MYRISTATE;

ACTIN FILAMENT; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSKELETON; IMMUNOPRECIPITATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; RAT; SMOOTH MUSCLE FIBER; STIMULATION; ANIMAL; BIOLOGICAL MODEL; CELL FRACTIONATION; CELL LINE; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; GENE SILENCING; METABOLISM; PHOSPHORYLATION; PROTEIN TRANSPORT; SERUM; SOLUBILITY;

ACTIN CYTOSKELETON; ACTINS; ANIMALS; CALMODULIN-BINDING PROTEINS; CAVEOLIN 1; CELL LINE; ENZYME ACTIVATION; GENE KNOCKDOWN TECHNIQUES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MODELS, BIOLOGICAL; MYOCYTES, SMOOTH MUSCLE; PHOSPHORYLATION; PROTEIN TRANSPORT; RATS; SERUM; SOLUBILITY; SUBCELLULAR FRACTIONS; TETRADECANOYLPHORBOL ACETATE;

EID: 84857377693     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030409     Document Type: Article

References (44)

1. Kusuhara M, Chait A, Cader A, Berk BC, (1997) Oxidized LDL stimulates mitogen-activated protein kinases in smooth muscle cells and macrophages. Arterioscler Thromb Vasc Biol 17: 141-148.
2. Liao DF, Duff JL, Daum G, Pelech SL, Berk BC, (1996) Angiotensin II stimulates MAP kinase kinase kinase activity in vascular smooth muscle cells, Role of Raf. Circ Res 79: 1007-1014.
3. Touyz RM, Deng LY, He G, Wu XH, Schiffrin EL, (1999) Angiotensin II stimulates DNA and protein synthesis in vascular smooth muscle cells from human arteries: role of extracellular signal-regulated kinases. J Hypertens 17: 907-916.
4. Xu Q, Liu Y, Gorospe M, Udelsman R, Holbrook NJ, (1996) Acute hypertension activates mitogen-activated protein kinases in arterial wall. J Clin Invest 97: 508-514.
5. Hu Y, Dietrich H, Metzler B, Wick G, Xu Q, (2000) Hyperexpression and activation of extracellular signal-regulated kinases (ERK1/2) in atherosclerotic lesions of cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol 20: 18-26.
6. Ishihata A, Tasaki K, Katano Y, (2002) Involvement of p44/42 mitogen-activated protein kinases in regulating angiotensin II- and endothelin-1-induced contraction of rat thoracic aorta. Eur J Pharmacol 445: 247-256.
7. Je HD, Gangopadhyay SS, Ashworth TD, Morgan KG, (2001) Calponin is required for agonist-induced signal transduction-evidence from an antisense approach in ferret smooth muscle. J Physiol 537: 567-577.
8. Xiao D, Zhang L, (2002) ERK MAP kinases regulate smooth muscle contraction in ovine uterine artery: effect of pregnancy. Am J Physiol Heart Circ Physiol 282: H292-300.
9. Kim J, Lee YR, Lee CH, Choi WH, Lee CK, et al. (2005) Mitogen-activated protein kinase contributes to elevated basal tone in aortic smooth muscle from hypertensive rats. Eur J Pharmacol 514: 209-215.
10. Dhanasekaran DN, Kashef K, Lee CM, Xu H, Reddy EP, (2007) Scaffold proteins of MAP-kinase modules. Oncogene 26: 3185-3202.
11. Pouyssegur J, Volmat V, Lenormand P, (2002) Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling. Biochem Pharmacol 64: 755-763.
12. Sen A, O'Malley K, Wang Z, Raj GV, Defranco DB, et al. (2010) Paxillin regulates androgen- and epidermal growth factor-induced MAPK signaling and cell proliferation in prostate cancer cells. J Biol Chem 285: 28787-28795.
13. Wang JB, Sonn R, Tekletsadik YK, Samorodnitsky D, Osman MA, (2009) IQGAP1 regulates cell proliferation through a novel CDC42-mTOR pathway. J Cell Sci 122: 2024-2033.
14. Furuchi T, Anderson RG, (1998) Cholesterol depletion of caveolae causes hyperactivation of extracellular signal-related kinase (ERK). J Biol Chem 273: 21099-21104.
15. Galbiati F, Volonte D, Engelman JA, Watanabe G, Burk R, et al. (1998) Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. EMBO J 17: 6633-6648.
16. Je HD, Gallant C, Leavis PC, Morgan KG, (2004) Caveolin-1 regulates contractility in differentiated vascular smooth muscle. Am J Physiol Heart Circ Physiol 286: H91-98.
17. Luo DX, Cheng J, Xiong Y, Li J, Xia C, et al. (2010) Static pressure drives proliferation of vascular smooth muscle cells via caveolin-1/ERK1/2 pathway. Biochem Biophys Res Commun 391: 1693-1697.
18. Peterson TE, Guicciardi ME, Gulati R, Kleppe LS, Mueske CS, et al. (2003) Caveolin-1 can regulate vascular smooth muscle cell fate by switching platelet-derived growth factor signaling from a proliferative to an apoptotic pathway. Arterioscler Thromb Vasc Biol 23: 1521-1527.
19. Sathish V, Yang B, Meuchel LW, VanOosten SK, Ryu AJ, et al. (2011) Caveolin-1 and force regulation in porcine airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 300: L920-929.
20. Gosens R, Stelmack GL, Bos ST, Dueck G, Mutawe MM, et al. (2010) Caveolin-1 is Required for Contractile Phenotype Expression by Airway Smooth Muscle Cells. J Cell Mol Med.
21. Firulli AB, Han D, Kelly-Roloff L, Koteliansky VE, Schwartz SM, et al. (1998) A comparative molecular analysis of four rat smooth muscle cell lines. In Vitro Cell Dev Biol Anim 34: 217-226.
22. Gimona M, Kaverina I, Resch GP, Vignal E, Burgstaller G, (2003) Calponin repeats regulate actin filament stability and formation of podosomes in smooth muscle cells. Mol Biol Cell 14: 2482-2491.
23. Kimes BW, Brandt BL, (1976) Characterization of two putative smooth muscle cell lines from rat thoracic aorta. Exp Cell Res 98: 349-366.
24. Burgstaller G, Gimona M, (2005) Podosome-mediated matrix resorption and cell motility in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 288: H3001-3005.
25. Gu Z, Kordowska J, Williams GL, Wang CL, Hai CM, (2007) Erk1/2 MAPK and caldesmon differentially regulate podosome dynamics in A7r5 vascular smooth muscle cells. Exp Cell Res 313: 849-866.
26. Zhang Y, Cincotta AH, (1997) Inhibitory effects of bromocriptine on vascular smooth muscle cell proliferation. Atherosclerosis 133: 37-44.
27. Campbell DH, Sutherland RL, Daly RJ, (1999) Signaling pathways and structural domains required for phosphorylation of EMS1/cortactin. Cancer Res 59: 5376-5385.
28. Childs TJ, Watson MH, Sanghera JS, Campbell DL, Pelech SL, et al. (1992) Phosphorylation of smooth muscle caldesmon by mitogen-activated protein (MAP) kinase and expression of MAP kinase in differentiated smooth muscle cells. J Biol Chem 267: 22853-22859.
29. Ishibe S, Joly D, Liu ZX, Cantley LG, (2004) Paxillin serves as an ERK-regulated scaffold for coordinating FAK and Rac activation in epithelial morphogenesis. Mol Cell 16: 257-267.
30. Menice CB, Hulvershorn J, Adam LP, Wang CA, Morgan KG, (1997) Calponin and mitogen-activated protein kinase signaling in differentiated vascular smooth muscle. J Biol Chem 272: 25157-25161.
31. Atten MJ, Attar BM, Holian O, (1998) Cytoskeletal PKC and ERK/MAPK activation in response to N-nitrosamines and phorbol 12-myristate 13-acetate in gastric adenocarcinoma cells. Anticancer Res 18: 4377-4382.
32. Leinweber BD, Leavis PC, Grabarek Z, Wang CL, Morgan KG, (1999) Extracellular regulated kinase (ERK) interaction with actin and the calponin homology (CH) domain of actin-binding proteins. Biochem J 344 Pt 1: 117-123.
33. McNicol A, Shibou TS, Pampolina C, Israels SJ, (2001) Incorporation of map kinases into the platelet cytoskeleton. Thromb Res 103: 25-34.
34. Schrick C, Fischer A, Srivastava DP, Tronson NC, Penzes P, et al. (2007) N-cadherin regulates cytoskeletally associated IQGAP1/ERK signaling and memory formation. Neuron 55: 786-798.
35. Bharadwaj S, Vasanth G, Masuelli L, Thanawala R, Prasad GL, (2008) Inhibition of Nuclear Accumulation of Phosphorylated ERK by Tropomyosin-1-Mediated Cytoskeletal Reorganization. J Cancer Mol 4: 139-144.
36. Hunter I, Mascall KS, Ramos JW, Nixon GF, (2011) A phospholipase Cgamma1-activated pathway regulates transcription in human vascular smooth muscle cells. Cardiovasc Res 90: 557-564.
37. Khalil RA, Menice CB, Wang CL, Morgan KG, (1995) Phosphotyrosine-dependent targeting of mitogen-activated protein kinase in differentiated contractile vascular cells. Circ Res 76: 1101-1108.
38. Alberola-Ila J, Forbush KA, Seger R, Krebs EG, Perlmutter RM, (1995) Selective requirement for MAP kinase activation in thymocyte differentiation. Nature 373: 620-623.
39. Bashey A, Healy L, Marshall CJ, (1994) Proliferative but not nonproliferative responses to granulocyte colony-stimulating factor are associated with rapid activation of the p21ras/MAP kinase signalling pathway. Blood 83: 949-957.
40. Marte BM, Graus-Porta D, Jeschke M, Fabbro D, Hynes NE, et al. (1995) NDF/heregulin activates MAP kinase and p70/p85 S6 kinase during proliferation or differentiation of mammary epithelial cells. Oncogene 10: 167-175.
41. Carrillo-Sepulveda MA, Barreto-Chaves ML, (2010) Phenotypic modulation of cultured vascular smooth muscle cells: a functional analysis focusing on MLC and ERK1/2 phosphorylation. Mol Cell Biochem 341: 279-289.
42. Roy J, Kazi M, Hedin U, Thyberg J, (2001) Phenotypic modulation of arterial smooth muscle cells is associated with prolonged activation of ERK1/2. Differentiation 67: 50-58.
43. Horowitz A, Menice CB, Laporte R, Morgan KG, (1996) Mechanisms of smooth muscle contraction. Physiol Rev 76: 967-1003.
44. Vetterkind S, Illenberger S, Kubicek J, Boosen M, Appel S, et al. (2005) Binding of Par-4 to the actin cytoskeleton is essential for Par-4/Dlk-mediated apoptosis. Exp Cell Res 305: 392-408.